Vipulkumar Prajapati, MD
Co-Associate Director of Transfusion Medicine and Apheresis; Assistant Professor
Department: Pathology
Phone: (804) 828-3443
Email: Vipulkumar.Prajapati@vcuhealth.org
Vipulkumar Prajapati, MD, is the Associate Director of Transfusion Medicine and Apheresis Services and an Assistant Professor of Pathology at Virginia Commonwealth University Health System.
Dr. Prajapati graduated from P.D.U. Medical College, Rajkot, India, and completed post-graduation training in Human Anatomy at B.J. Medical College, Ahmedabad, India. He worked as an Assistant Professor of Anatomy before moving to the United States to pursue a residency in Pathology. He completed his Clinical Pathology residency, Hematopathology Fellowship, and Transfusion Medicine Fellowship at the University of Texas Health Science Center, San Antonio. During the fellowship training, he was honored with the Rolf Sjuve Scott Award - 2023.
Dr. Prajapati's clinical and research interests are alloimmunization, red cell exchange, and CAR-T cell therapy. He is one of the authors of “Ace the Boards - Hematopathology Review MCQ” and a reviewer of the “Ace the Boards - Neoplastic Hematopathology”. He enjoys teaching and working with medical students and residents, and likes to make a positive difference in their lives.
Contact Dr. Prajapati for a full CV
Print/Download Dr. Prajapati Web CV (pdf)
Dr. Vipulkumar Prajapati abbreviated CV
Education
2023 - 2024 Transfusion Medicine Fellow, University of Texas Health Science Center San Antonio, Texas
2022 - 2023 Hematopathology Fellow, University of Texas Health Science Center San Antonio, Texas
2019 - 2022 Resident, Clinical Pathology, University of Texas Health Science Center San Antonio, Texas
2008 - 2011 Resident, Human Anatomy, B. J. Medical College, Ahmedabad, Gujarat, India
2001 - 2007 MBBS (Medical Education), P.D.U. Medical College, Rajkot, Gujarat, India
Licenses & Certifications
Virginia Medical License
Pennsylvania Medical License
2022 American Board of Pathology – Clinical Pathology
2023 American Board of Pathology – Hematopathology
Awards
2023 Rolf Sjuve Scott Award, University of Texas Health Science Center, San Antonio, Texas
2023 Inspector Excellence, College of American Pathologists (CAP)
Professional Service (outside)
2024 - Present Accredited Laboratory Inspector, College of American Pathologists (CAP)
2024 - Present Apheresis Physician Committee member for the American Society for Apheresis (ASFA)
2024 - Present Apheresis Attending Physician Subcommittee member for the ASFA
2025 - Present Selection of Abstracts Committee, Association for the Advancement of Blood & Biotherapies (AABB)
2022 - Present American Society for Apheresis (ASFA)
2024 - Present Association for the Advancement of Blood & Biotherapies (AABB)
2018 - Present American Society for Clinical Pathology (ASCP)
2020 - Present College of American Pathologists (CAP)
2024 - Present Virginia Society of Pathologists (VSP)
2019 - 2025 Texas Society of Pathologists (TSP)
Recent Publications
Journal Reviewer: 2024 - Present
American Journal of Clinical Pathology (ASCP) Case Reports
Book Chapter
Ace the boards - Hematopathology Review MCQ book, First Edition
Book Reviewer
Ace the Boards - Neoplastic Hematopathology, Second Edition
Abstracts
Prevalence of high phosphatidylethanol (PEth) concentrations in a blood transfusion product. Williams, G., Keller, J., Prajapati, V., DelBaugh, R., Sanford, K., Poklis, J., Nanco, C., & Wolf, C. Clinical Chemistry, 71(Supplement 1), i292, 2025
Every Platelet Counts: Reducing Waste with Predictive Inventory Management System. Squyars, K., Buscema, G., DelBaugh, R., Prajapati, V., & Sanford, K., Presented at the AABB Annual Meeting, October 2025
How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood. Rahaf Alkhateb, Kirea Mazzolini, Vipulkumar Prajapati, Chantal Harrison, Kayla E. Ireland, Donald Jenkins, John Daniels, Leslie Greebon. Transfusion. March 2025;1–8
Isolated thrombocytosis with BCR::ABL1 gene rearrangement – a distinct entity or a variant of chronic myelogenous leukemia (CML)? Case report and review of literature. Prajapati, V., Flores, R. R., Nooruddin, Z. I., Medina, E. A., Purnell, G., Ehman, W., Rodriguez, J., Kane, S., Ortega, V., & Velagaleti, G. V. N. (2025). Human Pathology Reports, 41, 300785
DelBaugh RM, Murphy MF, Staves J, Fachini RM, Wendel S, Hands K, Bonet-Bub C, Kutner JM, Cohn CS, Cox CA, Jacquot C, Hasan RA, Lu W, Juskewitch JE, Raval JS, Rollins-Raval MA, Fung MK, Ziman A, Fermon EJ, Gorlin JB, Peters J, Dunbar NM; BEST foRmation of Anti‐D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study. Transfusion. 2025 May;65(5):957-967. doi: 10.1111/trf.18202. Epub 2025 Mar 10. PMID: 40059673
Prehospital Whole Blood Administration Not Associated with Increased Transfusion Reactions: The Experience of a Metropolitan EMS Agency. Raetz E, Wampler D, Greebon L, Jenkins D, Brigmon E, Messenger J, Prajapati V, Bullock W, Rayas E, Barry L, Ferguson B, Ely R, Winckler C. Prehosp Emerg Care. 2026;30(1):169-173. 2025 Feb 21. PMID: 39946294
Transfusion of Whole Blood Is Not Associated With Increased Rate of Hemolytic Transfusion Reaction. Samantha Murphy, MD, MC, USAF, Aaron Russell, BS , Daniel Meaders, BS , David Limon, MD, Lauran Barry, CCRC, Vipulkumar Prajapati, MD ; Leslie Greebon, MD , Erika Brigmon, MD, Donald Jenkins, MD, Military Medicine, 19 March 2025. PMID: 40105943
Angioimmunoblastic T-Cell Lymphoma (AITL) In A Systemic Polyclonal Immunoblastic Proliferation (SPIP) Background. Vipulkumar Prajapati, Apeksha Agarwal, Kenneth Holder; Society for Hematopathology- European Association for Hematopathology, 2023 workshop
Chronic Lymphoproliferative Disorder of NK cells Associated with a Clonal T-cell Large Granular Lymphocyte Proliferation. Apeksha Agarwal, Vipulkumar Prajapati, Russel Higgins; Society for Hematopathology- European Association for Hematopathology, 2023 workshop
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Hematological Neoplasm. Vipulkumar Prajapati, Apeksha Agarwal, Andrea Yunes. Texas Society of Pathologist Annual meet Jan 2022
Voxelotor Interference with Hemoglobin Electrophoresis- A Report of 2 Cases. Apeksha N Agarwal, MD, Vipulkumar Prajapati, MD, Julie M Fischer, MD, Melissa Frei-Jones, MD, Russell Higgins, MD; Texas Society of Pathologist Annual meet Jan 2022
RhD negative women transfused RhD positive blood: Alloimmunization prophylaxis protocol and experiences. Rahaf Alkhateb MD, Vipulkumar Prajapati MD, John Daniels DO, Leslie Greebon MD, American Society for Clinical Pathology (ASCP) Annual meeting, 2021
Extramedullary Monoblastic Sarcoma / Medullary Sarcoma of Paraspinal Region Without Myeloid Leukemia: A Rare Case Report. Prajapati V. P., Modi M. B., Madabhavi I., Kavani H., Shah M. R. (October 2018). Poster presented at: American Society for Clinical pathology (ASCP) Annual Meeting; 2018
HER 2/NEU Expression In Breast Cancers And Its Various Correlation With ER/PR Status And Various Clinical And Histological Parameters. Prajapati V. P., Modi M. B., Madabhavi I., Shah M. R., Sarkar M. (October 2018). Poster presented at: American Society for Clinical Pathology (ASCP) Annual Meeting; 2018
Print/Download Dr. Prajapati Web CV (pdf)